We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$253M
AUM Growth
-$16M
Cap. Flow
+$286M
Cap. Flow %
113.05%
Top 10 Hldgs %
44%
Holding
60
New
10
Increased
18
Reduced
9
Closed
22

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$260M
2
TMO icon
Thermo Fisher Scientific
TMO
+$26M
3
NVO
Novo Nordisk
NVO
+$14.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$13.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$11.6M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$8.31M
2
SNY icon
Sanofi
SNY
+$7.53M
3
BSX icon
Boston Scientific
BSX
+$6.54M
4
AMGN icon
Amgen
AMGN
+$6.03M
5
THC icon
Tenet Healthcare
THC
+$5.67M

Sector Composition

Rank Sector Weight
1 Healthcare 98.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$132B
$18.5M 7.29%
320,000
+190,000
+146% +$11.6M
COR icon
2
Cencora
COR
$61.2B
$12.6M 4.96%
+40,000
New +$3.52M
SNN icon
3
Smith & Nephew
SNN
$12.6B
$12.1M 4.79%
135,187
+60,187
+80% +$2.67M
INCY icon
4
Incyte
INCY
$24.4B
$11.4M 4.5%
115,000
+75,000
+188% +$5.67M
UNH icon
5
UnitedHealth
UNH
$370B
$10.6M 4.18%
42,500
+15,000
+55% +$4.13M
DHR icon
6
Danaher
DHR
$144B
$10.2M 4.02%
129,720
+73,320
+130% +$9.88M
AZN icon
7
AstraZeneca
AZN
$250B
$10.1M 4%
37,500
-25,000
-40% -$2.35M
MCK icon
8
McKesson
MCK
$101B
$9.22M 3.64%
+32,500
New +$4.76M
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$12.4B
$8.39M 3.31%
235,000
+155,000
+194% +$13.4M
CNC icon
10
Centene
CNC
$32.5B
$8.39M 3.31%
175,000
+40,000
+30% +$2.43M
NVO
11
Novo Nordisk
NVO
$209B
$8.16M 3.22%
+500,000
New +$14.9M
EHC icon
12
Encompass Health
EHC
$12.4B
$7.73M 3.05%
+40,853
New +$2.36M
HCA icon
13
HCA Healthcare
HCA
$89.5B
$7.5M 2.96%
95,000
+32,500
+52% +$4.21M
CI icon
14
Cigna
CI
$74.6B
$7.49M 2.96%
45,000
+5,000
+13% +$970K
CAH icon
15
Cardinal Health
CAH
$55.4B
$7.31M 2.88%
+90,000
New +$4.67M
ISRG icon
16
Intuitive Surgical
ISRG
$134B
$6.99M 2.76%
1,456,569
+1,419,069
+3,784% +$260M
SYK icon
17
Stryker
SYK
$130B
$6.94M 2.74%
50,000
+25,000
+100% +$4.88M
HUM icon
18
Humana
HUM
$46.2B
$6.92M 2.73%
50,000
+22,500
+82% +$7.59M
UHS icon
19
Universal Health Services
UHS
$10.5B
$6.54M 2.58%
65,000
+10,000
+18% +$1.27M
BIIB icon
20
Biogen
BIIB
$30.7B
$6.33M 2.5%
20,000
– –
CTLT
21
DELISTED
CATALENT, INC.
CTLT
$6.02M 2.38%
+100,000
New +$5.46M
MRK icon
22
Merck
MRK
$318B
$5.12M 2.02%
83,840
+5,240
+7% +$412K
ABT icon
23
Abbott
ABT
$187B
$5M 1.97%
65,000
+5,000
+8% +$417K
PRGO icon
24
Perrigo
PRGO
$1.78B
$4.95M 1.95%
+65,000
New +$3.49M
REGN icon
25
Regeneron Pharmaceuticals
REGN
$80.8B
$4.88M 1.93%
10,000
-10,000
-50% -$4.12M
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2020 Portfolio in Review

As of Q1 2020, Sivik Global Healthcare held 60 positions worth $253M, down 5.9% from $269M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sivik Global Healthcare deployed $286M of net new capital in Q1 2020, opening 10 new positions and adding to 18 existing holdings. Its largest new stake was Novo Nordisk: 500,000 shares worth $8.16M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $6.54M trimmed.

  • Sivik Global Healthcare's largest Q1 2020 buy was Novo Nordisk: 500,000 shares worth $8.16M.
  • Sivik Global Healthcare added most to Intuitive Surgical in Q1 2020, an estimated $260M increase.
  • Sivik Global Healthcare's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $6.54M.
  • Sivik Global Healthcare fully exited Elevance Health in Q1 2020, selling an estimated $8.31M.
  • Sivik Global Healthcare's ten largest holdings make up 44% of its $253M portfolio in Q1 2020.
  • Sivik Global Healthcare opened 10 new positions and closed 22 in Q1 2020.
  • Sivik Global Healthcare's portfolio value fell 5.9% quarter-over-quarter to $253M.

Based on Sivik Global Healthcare's 13F filing for Q1 2020, filed 15 May 2020.